No Data
No Data
Optimi Health Secures Certification for 40mg and 60mg MDMA GMP Capsules | CSE:OPTI, OTCQB:OPTHF
Optimi Health Corp. Expands Global Reach With MDMA Export
Early Warning Press Release in Accordance With National Instrument 62-103
Vancouver, British Columbia--(Newsfile Corp. - April 4, 2024) - Cathay Visions Enterprises Ltd. (the "Acquiror") acquired 110,000 common shares (each a "Common Share") of Optimi Health Corp. (the "Iss
Optimi Health to Supply MDMA for Psychedelic Research at Tel Aviv University
Optimi Health Corp. (OPTI.CN), specializing in controlled substances such as natural psilocybin and MDMA, has entered into an international MDMA supply agreement with The Institute for Psychedelic Res
Optimi Health Granted Precursor Licence to Formulate MDMA, Completes Encapsulation Of Two Dosage Formats
Optimi Health Corp. (OPTI.CSE) a licensed drug researcher and formulator specializing in controlled psychedelic substances such as natural psilocybin and MDMA, announces that it has been granted its P
Optimi Health Says Achieved Genetics Milestone and Completed Psilocybin Extract Validation and Stability Testing
Optimi Health Corp. (OPTI.CSE) on Tuesday reports that it has achieved a significant milestone. The company has harvested eight new natural psilocybin genetics. Optimi cultivated these [pilocybin-cont